Trump Administration Eases Opioid Ban After Kratom Industry Lobbying
Health officials will permit some levels of a potent substance in products marketed as natural following kratom industry lobbying.
AI-written summary · The Chestnut Post · · How we use AI

The Trump administration has softened its position on an opioid ban following lobbying by the kratom industry, according to The New York Times.
Health officials will permit some amounts of a potent substance to remain in products promoted as natural, rather than prohibit it entirely.
The shift could benefit a Republican donor who faces wrongful death lawsuits, the Times reported.
Originally reported by The New York Times. Read the full story at The New York Times


